377 related articles for article (PubMed ID: 3128401)
1. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
Sampson-Johannes A; Carlino JA
J Immunol; 1988 Nov; 141(10):3680-6. PubMed ID: 3053901
[TBL] [Abstract][Full Text] [Related]
4. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colony-stimulating factor.
Blanchard DK; Serbousek D; Djeu JY
Cancer Res; 1989 Sep; 49(18):5037-43. PubMed ID: 2670200
[TBL] [Abstract][Full Text] [Related]
5. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
Hancock WW; Pleau ME; Kobzik L
J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity.
Hart PH; Whitty GA; Piccoli DS; Hamilton JA
J Immunol; 1988 Sep; 141(5):1516-21. PubMed ID: 3137258
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF.
Wang M; Friedman H; Djeu JY
J Immunol; 1989 Jul; 143(2):671-7. PubMed ID: 2661688
[TBL] [Abstract][Full Text] [Related]
8. Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
Wiltschke C; Krainer M; Wagner A; Linkesch W; Zielinski CC
Exp Hematol; 1995 May; 23(5):402-6. PubMed ID: 7536681
[TBL] [Abstract][Full Text] [Related]
9. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
Rifkin RM; Hersh EM; Salmon SE
Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
[TBL] [Abstract][Full Text] [Related]
10. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
[TBL] [Abstract][Full Text] [Related]
11. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
Curley SA; Roh MS; Kleinerman E; Klostergaard J
Lymphokine Res; 1990; 9(3):355-63. PubMed ID: 2118971
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
Falk LA; Hogan MM; Vogel SN
J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
[TBL] [Abstract][Full Text] [Related]
13. Modulation of in vitro antitumor immunity in response to the biological activators interleukin-2, gamma interferon, and granulocyte monocyte-colony stimulating factor in the peripheral blood of cancer patients receiving cytotoxic chemotherapy.
Harris JE; Braun DP
Bull N Y Acad Med; 1989 Jan; 65(1):16-25. PubMed ID: 2513993
[No Abstract] [Full Text] [Related]
14. Effect of recombinant hemopoietic growth factors on human megakaryocyte colony formation in serum-free cultures.
Teramura M; Katahira J; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
Exp Hematol; 1989 Nov; 17(10):1011-6. PubMed ID: 2680566
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
Falk LA; Wahl LM; Vogel SN
J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant and purified hematopoietic growth factors on human megakaryocyte colony formation.
Bruno E; Briddell R; Hoffman R
Exp Hematol; 1988 Jun; 16(5):371-7. PubMed ID: 2453373
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human alveolar macrophage tumoricidal activity by recombinant macrophage colony-stimulating factor.
Thomassen MJ; Barna BP; Wiedemann HP; Ahmad M
J Biol Response Mod; 1990 Feb; 9(1):87-91. PubMed ID: 2156955
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.
Wing EJ; Magee DM; Whiteside TL; Kaplan SS; Shadduck RK
Blood; 1989 Feb; 73(3):643-6. PubMed ID: 2465038
[TBL] [Abstract][Full Text] [Related]
19. Induction of monocyte migration by recombinant macrophage colony-stimulating factor.
Wang JM; Griffin JD; Rambaldi A; Chen ZG; Mantovani A
J Immunol; 1988 Jul; 141(2):575-9. PubMed ID: 3290341
[TBL] [Abstract][Full Text] [Related]
20. Biological effects of recombinant human GM-CSF.
Shadduck RK; Kaplan SS; Whiteside TL; Wing EJ
Prog Clin Biol Res; 1990; 352():365-74. PubMed ID: 2169633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
